M&T Bank Corp Illumina, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Illumina, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 54,378 shares of ILMN stock, worth $7.77 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

54,378

Previous 54,378 -0.0%

Holding current value

$7.77 Million

Previous $7.09 Million -0.0%

% of portfolio

0.02%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$105.28 - $135.9 $186,240 - $240,407	1,769 Added 3.36%	54,378 $7.09 Million
Q2 2024 Jul 31, 2024	SELL	$101.05 - $133.57 $990,593 - $1.31 Million	-9,803 Reduced 15.71%	52,609 $5.49 Million
Q1 2024 May 07, 2024	BUY	$127.73 - $147.2 $766 - $883	6 Added 0.01%	62,412 $8.57 Million
Q4 2023 Feb 06, 2024	SELL	$92.79 - $142.53 $847,822 - $1.3 Million	-9,137 Reduced 12.77%	62,406 $8.69 Million
Q3 2023 Nov 02, 2023	SELL	$128.91 - $192.44 $482,767 - $720,687	-3,745 Reduced 4.97%	71,543 $9.82 Million
Q2 2023 Aug 09, 2023	BUY	$183.43 - $232.67 $1.72 Million - $2.19 Million	9,394 Added 14.26%	75,288 $14.1 Million
Q1 2023 May 11, 2023	BUY	$193.75 - $232.55 $1.13 Million - $1.36 Million	5,846 Added 9.74%	65,894 $15.3 Million
Q4 2022 Feb 13, 2023	BUY	$187.24 - $242.74 $13 Million - $16.8 Million	69,303 Added 961.61%	76,510 $15.5 Million
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $3.08 Million - $4 Million	-16,462 Reduced 21.52%	60,048 $12.1 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $113,781 - $146,016	642 Added 9.78%	7,207 $1.37 Million
Q2 2022 Aug 05, 2022	BUY	$181.58 - $368.0 $310,501 - $629,280	1,710 Added 35.22%	6,565 $1.15 Million
Q1 2022 May 09, 2022	SELL	$303.87 - $423.8 $617,159 - $860,737	-2,031 Reduced 29.49%	4,855 $1.69 Million
Q4 2021 Feb 07, 2022	SELL	$347.28 - $421.83 $37,158 - $45,135	-107 Reduced 1.53%	6,886 $2.62 Million
Q3 2021 Oct 28, 2021	SELL	$405.61 - $524.84 $111,542 - $144,331	-275 Reduced 3.78%	6,993 $2.84 Million
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $61,891 - $79,929	-166 Reduced 2.23%	7,268 $3.44 Million
Q1 2021 May 06, 2021	SELL	$361.28 - $504.76 $285,049 - $398,255	-789 Reduced 9.6%	7,434 $2.86 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $405,389 - $513,779	-1,385 Reduced 14.42%	8,223 $3.04 Million
Q3 2020 Nov 06, 2020	SELL	$268.51 - $400.74 $418,607 - $624,753	-1,559 Reduced 13.96%	9,608 $2.97 Million
Q2 2020 Jul 29, 2020	BUY	$256.46 - $373.01 $438,546 - $637,847	1,710 Added 18.08%	11,167 $4.14 Million
Q1 2020 May 14, 2020	SELL	$209.2 - $335.53 $748,936 - $1.2 Million	-3,580 Reduced 27.46%	9,457 $2.58 Million
Q4 2019 Feb 07, 2020	BUY	$288.29 - $335.49 $12,973 - $15,097	45 Added 0.35%	13,037 $4.33 Million
Q3 2019 Nov 12, 2019	SELL	$266.84 - $378.23 $86,722 - $122,924	-325 Reduced 2.44%	12,992 $3.95 Million
Q2 2019 Aug 12, 2019	SELL	$300.59 - $368.15 $219,130 - $268,381	-729 Reduced 5.19%	13,317 $4.9 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $149,368 - $176,006	-548 Reduced 3.75%	14,046 $4.36 Million
Q4 2018 Feb 01, 2019	BUY	$272.46 - $366.54 $225,596 - $303,495	828 Added 6.01%	14,594 $4.38 Million
Q3 2018 Nov 09, 2018	BUY	$279.04 - $367.06 $298,572 - $392,754	1,070 Added 8.43%	13,766 $5.05 Million
Q2 2018 Aug 10, 2018	BUY	$228.17 - $292.07 $6,616 - $8,470	29 Added 0.23%	12,696 $3.55 Million
Q1 2018 May 04, 2018	BUY	$209.54 - $253.91 $17,182 - $20,820	82 Added 0.65%	12,667 $2.99 Million
Q4 2017 Feb 06, 2018	SELL	$202.23 - $230.03 $8,089 - $9,201	-40 Reduced 0.32%	12,585 $2.75 Million
Q3 2017 Nov 13, 2017	SELL	$172.3 - $213.93 $18,436 - $22,890	-107 Reduced 0.84%	12,625 $2.52 Million
Q2 2017 Aug 11, 2017	BUY	N/A	12,732	12,732 $2.21 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account